Assertio Holdings Inc ASRT.OQ reported a quarterly adjusted loss of 17 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -4 cents. The mean expectation of five analysts for the quarter was for a loss of 8 cents per share. Wall Street expected results to range from -10 cents to -2 cents per share.
Revenue fell 6.1% to $29.22 million from a year ago; analysts expected $27.86 million.
Assertio Holdings Inc's reported EPS for the quarter was a loss of 17 cents.
The company reported a quarterly loss of $16.35 million.
Assertio Holdings Inc shares had risen by 13.7% this quarter and lost 16.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 26.7% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"
Wall Street's median 12-month price target for Assertio Holdings Inc is $3.00, about 75.7% above its last closing price of $0.73
This summary was machine generated from LSEG data August 11 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | -0.08 | -0.17 | Missed |
Mar. 31 2025 | -0.06 | -0.04 | Beat |
Dec. 31 2024 | -0.04 | -0.11 | Missed |
Sep. 30 2024 | -0.05 | -0.03 | Beat |